REAC® TECHNOLOGY

The REAC® Technology (Radio Electric Asymmetric Conveyor) was developed in the 1980s by Salvatore Rinaldi and Vania Fontani, who were medical students at the time. Their goal was ambitious: address one of the fundamental challenges of medicine with an innovative technological approach.

At the base of this technology is l?Endogenous Bioelectric Activity, a process that allows each cell to generate and regulate its own vital energy, essential for all physiological functions. Even minimal alterations of this mechanism can contribute to the onset of disorders and pathologies, including changes in genetic expression (epigenetics) and complex conditions such as tumors.

REAC® Technology has been designed to intervene on these alterations, favoring the recovery of optimal bioelectrical conditions and the restoration of functional balance. Through a radioelectric field of very low intensity, conveyed by a special probe, the technology interacts with the organism according to predefined parameters. This approach represents a significant evolution in the treatment of functional alterations.

A new specialist branch

The development of REAC® Technology has been accompanied by extensive studies to understand the mechanisms that regulate EBA alterations and their impact on health. This process led to the definition of the Neuro-Psychic Physio-Adaptive Pathology, a new medical discipline that analyses how interactions between the environment and the body can affect health status.

This branch of medicine is based on a systemic view of pathologies, considering how the nervous system (Neuro), emotional responses (Psychic) and physiological functions (Physical Pathology) adapt over time, generating a new normal (Adaptive).

Clinical applications and innovation

The Rinaldi Fontani Institute, thanks to its constant commitment to research, has made possible the evolution of knowledge that led to the development of advanced therapeutic protocols. These protocols are designed to address cellular bioelectrical alterations in a specific and increasingly personalized way, positively influencing the epigenetic response and the course of diseases.

These innovative treatments, combined with the latest generation REAC equipment, are available exclusively at the Rinaldi Fontani Institute, recognized as a clinical reference point, research and training in the field of Neuro-Psychic Physio-Adaptive Pathology and REAC technology.

A research-based approach

REAC® Technology is not only the result of a technological revolution, but is an integral part of a clinical and scientific approach that focuses on identifying and treating the root causes of functional alterations. Thanks to decades of research, the Rinaldi Fontani Institute continues to develop therapeutic solutions that combine scientific rigor and technological innovation, with the aim of improving the health and well-being of patients.